Company news

Iovance Biotherapeutics, Inc. news in 2019

Iovance Biotherapeutics, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy

November 20, 2019

Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer 34th Annual Meeting

November 7, 2019

Iovance Biotherapeutics Reports Third Quarter and September Year-to-Date 2019 Financial Results

November 3, 2019

Iovance Biotherapeutics Announces Four Abstracts to be Presented at the Upcoming 2019 SITC Annual Meeting

October 1, 2019

Decks in 2019